# Efficacy of RAD001 in Breast Cancer Patients With Bone Metastases

> **NCT00466102** · PHASE2 · UNKNOWN · sponsor: **GBG Forschungs GmbH** · enrollment: 130 (estimated)

## Conditions studied

- Breast Cancer

## Interventions

- **DRUG:** RAD001
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT00466102
- **Lead sponsor:** GBG Forschungs GmbH
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2006-12
- **Primary completion:** 2010-12
- **Final completion:** 2012-12
- **Target enrollment:** 130 (ESTIMATED)
- **Last updated:** 2012-08-30

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00466102

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00466102, "Efficacy of RAD001 in Breast Cancer Patients With Bone Metastases". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT00466102. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*